Atria Wealth Solutions, Inc. - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 61 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
Atria Wealth Solutions, Inc. ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$498,816
+32.8%
259,800
-0.4%
0.01%
+40.0%
Q2 2023$375,552
-32.1%
260,800
-0.9%
0.01%
-37.5%
Q1 2023$552,930
+80.8%
263,300
-2.7%
0.01%
+60.0%
Q4 2022$305,891
-32.7%
270,700
-2.9%
0.01%
-37.5%
Q3 2022$454,281
+23.1%
278,700
-1.1%
0.01%
+14.3%
Q2 2022$369,000
-19.8%
281,700
-1.4%
0.01%
-12.5%
Q1 2022$460,000285,7000.01%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$401,0000.10%
Geneos Wealth Management Inc. 511,606$2,261,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$26,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 18,967$41,0000.01%
Vivaldi Capital Management LP 10,668$45,0000.01%
OSAIC HOLDINGS, INC. 1,221,984$2,651,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$34,0000.00%
WEDBUSH SECURITIES INC 17,998$39,0000.00%
D.A. DAVIDSON & CO. 65,310$142,0000.00%
Virtu Financial LLC 14,683$32,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders